At a glance
ClinicalIndex Comparison RecordN/AUnknown· 130 target
Drug / intervention
No treatment is included in this studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-interventional Study and Its Clinical Relevance With Advanced Lung Squamous Cell Carcinoma
In Brief
An observational study evaluating No treatment is included in this study for Advanced Lung Squamous Cell Carcinoma. Targeting 130 participants across 1 site.
Detailed Summary
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Lung Squamous Cell Carcinoma
CountriesChina
Collaborators--
Timeline
N/AUnknownOverdue
20222023202420252026
Enrollment StartJul 2021
First PostedAug 2023
Primary CompletionDec 2024
Study CompletionDec 2025
TodayJul 2026
First PostedAug 9, 2023
Enrollment StartJul 1, 2021
Primary CompletionDec 31, 2024
Study CompletionDec 31, 2025
TodayJul 1, 2026
Enrollment to primary: 3.5 yearsPosted 2.9 years ago
Interventions
No treatment is included in this studyother
No drug intervention or tissue sampling will be included in this study.